USING OF B-BLOCKERS FOR TOPICAL HAEMANGIOMA TREATMENT
Keywords:haemangioma, pediatric ophthalmology, B-blockers
Infantile haemangioma is the most common tumour in newborn. Nowadays, we have a lot of methods for haemangioma treatment, but we still don’t have criteria to choose treatment way and one universal strategy.
Since 2008, both topical and systemic -blockers have been using for haemangioma treatment. First publication about using -blockers for hemangioma treatment appeared in 2010.
Aim: to study effi cacy of topical -blockers for haemangioma treatment.
Materials and methodos: during January 2012 – January 2015 150 patients with different localised haemangiomas were treated in our department, 30 of these patients were included in investigation. Patients were divided in 4 groups: 1st – superfi cial haemangioma of eyelid (6 patients), 2nd group – profound periorbital haemangioma (7 patients), 3rd group – periorbital haemangioma with mix type of grossing (14 patients), 4th group superfi cial hemangioma other localization (3 patients). First line of therapy consisted of timolol application. Second line of therapy consisted of timolol in combination with dimexidum in concentration 50:1 applied on haemangioma for 15 minutes 4 times per day. Results of treatment were registered after 2 weeks of treatment, and than every 4 weeks. Size of haemangioma was measured and photographed every 4 weeks.
Results: Treatment duration was 6 months (from 2 to 9 month), follow up period was 7 month (from 3 to 12 months) In all cases we observed answer to the treatment. First signs of disease regression were observed during fi rst week of treatment. 12 patients were excluded from investigation: 1 patient due to episode of bronchoobstruction (connection between timolol using and bronchoobstruction was not established), 2 patients started treatment with -blockers, 4 patients – started treatment with timogel, 5 patient was operated due to absence effect of treatment.
Summary. Described method could be used for treatment of superfi cial capillary haemangioma and for stabilisation of its sizes. Also this method is useful when other methods are contraindicated. It is necessary to use different treatment strategies for best curative and cosmetic effect. Mechanism of local effects of betablockers alone and in combination with dimexidum should be more deeply investigated.
Ovadia S.A. et al. Ann Plast Surg. 2015. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Review article.
Дементьєва Н.А., Мачур В.Й., Дігтяр В.А. Про природну та індуковану інволюцію дитячих гемангіом. Хірургія дитячого віку -2013 – №4, С. 16–22.
Тетруєва Н.А., Поворознюк В.С., Тополова К.В., Тимошенко А.В., Лучинский Д.В. Тактика лечения гемангиом челюстно-лицевой области у детей. Применение пропранолола в качестве первой линии терапии гемангиом сложных локализаций Хірургія дитячого віку – 2013 – №4, С. 24–31.
Дементьєва Н.А., Дігтяр В.А., Гладкий О.П. та ін. Застосування пропранололу в лікуванні гемангіом складних локалізацій у дітей. Клінічна онкологія – 2011 – №3 (3). – С. 57–60.
Gomathy Sethuraman, Vamsi K Yenamandra and Vishal Gupta. Management of Infantile Hemangiomas: Current Trends J Cutan Aesthet Surg. 2014 Apr-Jun; 7(2): 75–85.
Ohnishi K1, Tagami M1, Morii E2, Azumi A1.Topical Treatment for Orbital Capillary Hemangioma in an Adult Using a β-Blocker Solution. Case Rep Ophthalmol. 2014 Feb 20;5(1):60–5.
Xue K., Hildebrand G. Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5% drops. JAMA Ophthalmol. 2013;131:1246–1248.
Raul Mattassi, Dirk A. Loose, Massimo Vaghi. Hemangiomas and Vascular Malformation. An Atlas of Diagnosis and Treatment. Springer Verlag Italia 2009.
Copyright (c) 2019 Archive of Ukrainian Ophthalmology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.